[go: up one dir, main page]

IL129653A - Substituted amylose as a matrix for sustained drug release - Google Patents

Substituted amylose as a matrix for sustained drug release

Info

Publication number
IL129653A
IL129653A IL12965397A IL12965397A IL129653A IL 129653 A IL129653 A IL 129653A IL 12965397 A IL12965397 A IL 12965397A IL 12965397 A IL12965397 A IL 12965397A IL 129653 A IL129653 A IL 129653A
Authority
IL
Israel
Prior art keywords
matrix
sustained release
amylose
drug
drug release
Prior art date
Application number
IL12965397A
Other languages
English (en)
Other versions
IL129653A0 (en
Inventor
L Cartilier
I Moussa
C Chabli
S Buczkowski
Original Assignee
Univ Montreal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Montreal filed Critical Univ Montreal
Publication of IL129653A0 publication Critical patent/IL129653A0/xx
Publication of IL129653A publication Critical patent/IL129653A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IL12965397A 1996-10-30 1997-10-22 Substituted amylose as a matrix for sustained drug release IL129653A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/739,539 US5879707A (en) 1996-10-30 1996-10-30 Substituted amylose as a matrix for sustained drug release
PCT/CA1997/000792 WO1998018451A2 (fr) 1996-10-30 1997-10-22 Amylose substituee servant de matrice pour la liberation continue de medicaments

Publications (2)

Publication Number Publication Date
IL129653A0 IL129653A0 (en) 2000-02-29
IL129653A true IL129653A (en) 2005-06-19

Family

ID=24972771

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12965397A IL129653A (en) 1996-10-30 1997-10-22 Substituted amylose as a matrix for sustained drug release

Country Status (13)

Country Link
US (1) US5879707A (fr)
EP (1) EP0938300B1 (fr)
JP (1) JP4477144B2 (fr)
CN (1) CN1122535C (fr)
AT (1) ATE249814T1 (fr)
AU (1) AU719190B2 (fr)
BR (2) BRPI9712618B1 (fr)
CA (1) CA2271895C (fr)
DE (1) DE69724987T2 (fr)
ES (1) ES2207720T3 (fr)
HU (1) HU225037B1 (fr)
IL (1) IL129653A (fr)
WO (1) WO1998018451A2 (fr)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999029310A2 (fr) * 1997-12-05 1999-06-17 Medical College Of Georgia Research Institute, Inc. Regulation de l'immunite a mediation lymphocytaire, au moyen du tryptophane
US6284273B1 (en) * 1998-02-24 2001-09-04 Vincent Lenaerts Cross-linked high amylose starch resistant to amylase as a matrix for the slow release of biologically active compounds
US6299907B1 (en) * 1998-06-12 2001-10-09 Kansas State University Research Foundation Reversibly swellable starch products
US6607748B1 (en) 2000-06-29 2003-08-19 Vincent Lenaerts Cross-linked high amylose starch for use in controlled-release pharmaceutical formulations and processes for its manufacture
EP1174127A1 (fr) * 2000-07-21 2002-01-23 Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno Composition pour la libération ciblée d' un principe actif et procédé pour la préparation d' une telle composition
EP1485078B1 (fr) * 2002-03-15 2012-09-26 Cypress Bioscience, Inc. Milnacipran pour le traitement du syndrôme du colon irritable
US8487002B2 (en) * 2002-10-25 2013-07-16 Paladin Labs Inc. Controlled-release compositions
US20060003004A1 (en) * 2002-10-25 2006-01-05 Collegium Pharmaceutical, Inc. Pulsatile release compositions of milnacipran
TWI319713B (en) * 2002-10-25 2010-01-21 Sustained-release tramadol formulations with 24-hour efficacy
US20040121010A1 (en) * 2002-10-25 2004-06-24 Collegium Pharmaceutical, Inc. Pulsatile release compositions of milnacipran
US20040228830A1 (en) * 2003-01-28 2004-11-18 Collegium Pharmaceutical, Inc. Multiparticulate compositions of milnacipran for oral administration
US7598287B2 (en) 2003-04-01 2009-10-06 Medical College Of Georgia Research Institute, Inc. Use of inhibitors of indoleamine-2,3-dioxygenase in combination with other therapeutic modalities
US20050186289A1 (en) * 2003-04-01 2005-08-25 Medical College Of Georgia Research Institute, Inc. Regulation of T cell-mediated immunity by D isomers of inhibitors of indoleamine-2,3-dioxygenase
US20060172006A1 (en) * 2003-10-10 2006-08-03 Vincent Lenaerts Sustained-release tramadol formulations with 24-hour clinical efficacy
CA2491665A1 (fr) * 2004-12-24 2006-06-24 Louis Cartilier Formulation de comprime pour liberation soutenue de principe actif
ES2620293T3 (es) * 2005-09-09 2017-06-28 Paladin Labs Inc. Composición de liberación sostenida de fármacos
AU2006308449B8 (en) * 2005-09-09 2012-11-22 Angelini Labopharm, Llc Trazodone composition for once a day administration
ATE454908T1 (de) * 2005-09-21 2010-01-15 Surmodics Inc In situ okklusionszusammensetzungen mit natürlichen biologisch abbaubaren polysacchariden
ATE540705T1 (de) * 2005-09-21 2012-01-15 Surmodics Inc Überzüge und artikel mit natürlichen biologisch abbaubaren polysacchariden
AU2006306521B2 (en) * 2005-10-21 2011-12-22 Medical College Of Georgia Research Institute, Inc. The induction of indoleamine 2,3-dioxygenase in dendritic cells by TLR ligands and uses thereof
WO2007055329A1 (fr) * 2005-11-11 2007-05-18 Asahi Kasei Chemicals Corporation Preparation solide a liberation controlee
JP5819579B2 (ja) * 2006-01-13 2015-11-24 サーモディクス，インコーポレイティド 薬物送達のためのマトリックスを含む微粒子
EP2296630A2 (fr) * 2008-05-07 2011-03-23 SurModics, Inc. Administration de complexe d'acide nucléique à partir de particules
US8901092B2 (en) 2010-12-29 2014-12-02 Surmodics, Inc. Functionalized polysaccharides for active agent delivery
WO2015127537A1 (fr) * 2014-02-27 2015-09-03 B-Organic Films Corp. Agents bio-actifs inclus dans l'amidon fonctionnalisé ayant une structure en v à hélice unique
CN104291973B (zh) * 2014-09-26 2016-08-24 广州市高士实业有限公司 缓释载体及其在盆栽作物所需水分或肥料的缓释中的应用
CN108450545B (zh) * 2018-04-12 2021-08-13 天津商业大学 利用回生淀粉制备果蔬保鲜剂
CN114196076B (zh) * 2021-12-31 2023-04-28 昆山京昆油田化学科技有限公司 一种起泡胶及其制备方法和凝胶材料

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3034911A (en) * 1959-03-25 1962-05-15 Nat Starch Chem Corp Tablet disintegrants
US3163579A (en) * 1962-02-15 1964-12-29 Nat Starch Chem Corp Method for the entrapment of choline salts
GB978495A (en) * 1962-07-25 1964-12-23 Staley Mfg Co A E Amylose solutions
US3490742A (en) * 1966-01-14 1970-01-20 Staley Mfg Co A E Compressed tablets
US3622677A (en) * 1969-07-07 1971-11-23 Staley Mfg Co A E Compressed tablets containing compacted starch as binder-disintegrant ingredient
US4072535A (en) * 1970-12-28 1978-02-07 A. E. Staley Manufacturing Company Precompacted-starch binder-disintegrant-filler material for direct compression tablets and dry dosage capsules
JPS4837817B1 (fr) * 1970-12-31 1973-11-14
JPS5945002B2 (ja) * 1974-06-08 1984-11-02 ユニチカ株式会社 カルボキシアルキル化アミロ−スペレツトの製造法
DE3045135A1 (de) * 1980-11-29 1982-06-09 Sandoz-Patent-GmbH, 7850 Lörrach Pharmazeutische kompositionen enthaltende bioabbaubare polymere
US4369308A (en) * 1981-07-24 1983-01-18 National Starch And Chemical Corporation Low swelling starches as tablet disintegrants
US4985082A (en) * 1987-11-20 1991-01-15 Lafayette Applied Chemistry, Inc. Microporous granular starch matrix compositions
GB8812490D0 (en) * 1988-05-26 1988-06-29 Agricultural & Food Res Delayed release formulations
CA2041774C (fr) * 1990-11-27 1994-04-19 Mircea A. Mateescu Utilisation d'amylose reticulee en tant que matrice pour la liberation lente de composes biologiquement actifs
CA2032385A1 (fr) * 1990-12-17 1992-06-18 Chung Wai-Chiu Amidons debranches par un enzyme sous forme de comprimes
AU4109493A (en) * 1992-04-20 1993-11-18 Bruce K. Redding Jr. Method and apparatus for the modification of starch and other polymers
NL9201195A (nl) * 1992-07-03 1994-02-01 Tno Preparaat voor de gereguleerde afgifte van een werkzame stof en werkwijze ter bereiding van een dergelijk preparaat.
DE69302580T2 (de) * 1992-07-24 1996-09-26 Labopharm Inc., Ste-Therese, Quebec Vernetztes polyhydroxyl-material zur enzymatisch gesteuerten arzneistofffreisetzung
US5616343A (en) * 1993-03-25 1997-04-01 Labopharm, Inc. Cross-linked amylose as a binder/disintegrant in tablets

Also Published As

Publication number Publication date
DE69724987D1 (de) 2003-10-23
WO1998018451A3 (fr) 1998-08-06
US5879707A (en) 1999-03-09
JP2001502700A (ja) 2001-02-27
BR9712618A (pt) 1999-12-21
CA2271895C (fr) 2002-08-20
AU719190B2 (en) 2000-05-04
ATE249814T1 (de) 2003-10-15
BR9712618B1 (pt) 2008-11-18
CN1122535C (zh) 2003-10-01
DE69724987T2 (de) 2004-07-15
CN1235539A (zh) 1999-11-17
WO1998018451A2 (fr) 1998-05-07
JP4477144B2 (ja) 2010-06-09
HU225037B1 (en) 2006-05-29
BRPI9712618B1 (pt) 2009-07-21
AU4768997A (en) 1998-05-22
HUP0000256A2 (hu) 2000-06-28
HUP0000256A3 (en) 2000-08-28
EP0938300A2 (fr) 1999-09-01
ES2207720T3 (es) 2004-06-01
EP0938300B1 (fr) 2003-09-17
IL129653A0 (en) 2000-02-29
CA2271895A1 (fr) 1998-05-07

Similar Documents

Publication Publication Date Title
IL129653A0 (en) Substituted amylose as a matrix for sustained drug release
MD1233C2 (ro) Derivaţi de eritromicină, procedeu de preparare a lor şi compoziţie farmaceutică pe baza acestora
AU8118494A (en) Composition for drug delivery comprising nicotine or a derivative thereof and starch microspheres and method for the manufacturing thereof
AU691476B2 (en) Injectable taxane derivative based compositions
IE881916L (en) Press-coated dihydropyridine tablets
NZ332576A (en) Controlled-release pharmaceutical tablet containing a carrier based on cross-linked amylose and hydroxypropylmethylcellulose
AU2348988A (en) 4H-1-benzopyran-4-one derivative or its salt, processes for producing the same and pharmaceutical composition comprising the same as active ingredient
AU8259691A (en) 3-amidopyrazole derivatives, process for preparing these and pharmaceutical compositions containing them
IL118366A0 (en) Vitamin D derivatives a process for the preparation thereof and pharmaceutical compositions containing the same
AU7335696A (en) Water-soluble vitamin composition that provides excellent tablets and process for producing the same
AU4627096A (en) Pharmaceutical compositions in the form of slow release tablets based on high molecular weight polysaccharide granules
AU574024B2 (en) Polycaprolactone matrix for oral drug administration
CA2085258A1 (fr) Methode de promotion de la croissance d'animaux et composition pulverisees contenant des cellules microbiennes tuees de bacteries appartenant au genre clostridium
YU59400A (sh) Azabiciklični ligandi 5ht1 receptora
AU4106800A (en) Swallowable tablets with high content of n-acetylcysteine
HUT57774A (en) Process for producing triacetate derivative of antibiotic bu-3420t, as well as pharmaceutical compositions comprising bu-3420t triacetate
GB1409149A (en) Quecetin derivatives and pharmaceutical uses thereof
IL147901A0 (en) Phenanthroline-7-one derivatives and their therapeutic uses
WO2000017366A3 (fr) Composition pharmaceutique de pretraitement d'un patient necessitant un medicament ou un promedicament
CA2217238A1 (fr) Cellulose reticulee employee comme excipient de comprimes
WO2001012631A3 (fr) Derives d'ascididemine et leurs applications therapeutiques
AU1597288A (en) Compounds possessing beta-antagonistic and alpha-antagonistic properties, suitable for lowering the intraorbital pressure, pharmaceutical composition containing these compounds, utilization thereof
NO942076L (no) Farmasöytisk blanding
HUT57781A (en) Process for producing cytotoxic bicyclo (7.3.1) tridec-4-ene-2,6-diine derivatives and pharmaceutical compositions comprising such ring system
ES2026755A6 (es) Un procedimiento para preparar una formulacion farmaceutica que contiene 3'-azido-3'-desoxitimidina o uno de sus derivados farmaceuticamente aceptables.

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees